1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-123461
    Sul-121 hydrochloride Inhibitor
    Sul-121 hydrochloride是一种具有抗氧化能力的化合物,可有效抑制慢性阻塞性肺病(COPD)实验模型中的气道炎症和高反应性(AHR)。Sul-121 hydrochloride以剂量依赖性方式预防脂多糖诱导的气道中性粒细胞增多症和 AHR。Sul-121 hydrochloride还显示出降低人类气道平滑肌细胞中氧化应激标志物的能力。Sul-121 hydrochloride抑制 NF-κB 亚基 p65 的核易位,从而减少促炎细胞因子的释放。
    Sul-121 hydrochloride
  • HY-111172
    Inotilone

    烟碱酮

    Inhibitor
    Inotilone 是基质金属蛋白酶 MMP-2MMP-9 的抑制剂,可对抗肺癌细胞的转移。异诺替隆增强抗氧化酶的活性,以支持其抗转移活性。Inotilone 还抑制 IκBα 磷酸化和 NFκB p65 核转位,涉及 FAK、PI3K/AKT、MAPK 和 NFκB 通路。
    Inotilone
  • HY-118668
    ABD-350
    ABD-350 是一种抗吸收剂,具有抑制破骨细胞活性且不影响成骨细胞活性以及预防卵巢切除诱导的骨丢失的活性。ABD-350可抑制核因子-κB配体诱导的核因子κB磷酸化抑制剂,导致破骨细胞凋亡,但对成骨细胞功能无抑制作用,能有效预防卵巢切除小鼠的骨丢失,且不抑制甲状旁腺激素诱导的骨形成。
    ABD-350
  • HY-108538
    Ethacrynic acid D5 Inhibitor
    Ethacrynic acid D5 是 Ethacrynic acid 的氘代物。Ethacrynic acid 是一种利尿剂。Ethacrynic acid 是谷胱甘肽 S-转移酶 (GSTs) 的抑制剂。Ethacrynic acid 是 NF-κB 信号传导途径的有效抑制剂,并且还调节白三烯的形成。Ethacrynic acid 还抑制 L 型电压依赖性和储存操作的钙通道,从而导致气道平滑肌细胞松弛。Ethacrynic acid 具有抗炎特性,可减轻类维生素A诱导的小鼠耳部水肿。
    Ethacrynic acid D5
  • HY-N1333
    Rubioncolin C Inhibitor
    Rubioncolin C 通过诱导凋亡和自噬细胞死亡,抑制 NF-κBAkt/mTOR/P70S6K 通路在人癌细胞中发挥抗肿瘤活性。
    Rubioncolin C
  • HY-122007
    AM-0561 Inhibitor
    AM-0561 是一种 NIK 抑制剂 (Ki: 0.3 nM)。AM-0561 可降低 p52 水平。
    AM-0561
  • HY-N9955
    Isonardosinone Inhibitor
    Isonardosinone 是一种松香酮型倍半萜,可从 Valerianaceae 中分离得到。Isonardosinone 可抑制 NF-κB 和 MAPK 信号通路,抑制 Lipopolysaccharides (HY-D1056) 诱导的 BV2 小胶质细胞中诱导型一氧化氮合酶 (iNOS) 和环氧合酶-2 (COX-2) 的表达,并表现出抗炎活性。
    Isonardosinone
  • HY-122521
    Sootepin D Inhibitor
    Sootepin D (compound 6) 是一种来自子花顶芽的三萜,可抑制 TNF-α 诱导的 NF-κB 活性,IC50 为 8.3 μM。Sootepin D 具有抗炎活性。
    Sootepin D
  • HY-170692
    Hypoglycemic agent 3 Inhibitor
    Hypoglycemic agent 3 (Compound H26),科罗索酸衍生物,具有降脂和显著的降血糖作用,可作为一种降血糖剂。Hypoglycemic agent 3 通过靶向 MCCC1 来抑制胰岛素抵抗,可以用于二型糖尿病的研究。
    Hypoglycemic agent 3
  • HY-173129
    Anti-inflammatory agent 97
    Anti-inflammatory agent 97 (Compound 1l) 是一种抗炎剂,也能抑制氧化应激。Anti-inflammatory agent 97 能够抑制 DSS (HY-116282C) 诱导的溃疡性结肠炎小鼠模型中结肠缩短,并抑制结肠组织的炎症症状。Anti-inflammatory agent 97 能够调控炎症相关的 TLR4/NF-κB 信号通路和氧化应激相关的 Nrf2/HO-1 信号通路。
    Anti-inflammatory agent 97
  • HY-162170
    Anti-inflammatory agent 72 Inhibitor
    Anti-inflammatory agent 72 (compound 5) 是一种与苯甲酰肼杂化的新型白藜芦醇衍生物。Anti-inflammatory agent 72 通过激活 Nrf2 和抑制 NF-κB p65/iNOS、 MAPKs 信号通路发挥抗炎和抗氧化活性。
    Anti-inflammatory agent 72
  • HY-B0678R
    Metaxalone (Standard)

    美他沙酮 (标准品)

    Inhibitor
    Metaxalone (Standard) 是 Metaxalone 的分析标准品。本产品用于研究及分析应用。Metaxalone (AHR438; NSC170959) 是 FDA 批准的一种肌肉松弛剂。Metaxalone 主要作用于中枢神经系统,通过抑制多突触反射弧达到肌肉松弛的效果。此外,Metaxalone 是 MAO-A 的抑制剂,具有抗炎和抗氧化的作用。Metaxalone 在 IL-1β 处理的小胶质细胞中,可抑制 IL-1β 诱导的炎症表型,调节 NF-κB 等相关信号通路以及降低 MAO-A 表达和活性。
    Metaxalone (Standard)
  • HY-P10839
    NBD peptide Inhibitor
    NBD peptide 通过抑制 NEMO-IKK 复合物结合来抑制 NF-κB 信号通路。NBD peptide 通过阻断促炎细胞因子的产生而发挥出抗炎活性。NBD peptide 通过调节免疫细胞而表现出免疫抑制活性。NBD peptide 通过与细胞穿透肽 HIV-TAT 结合来增强其跨膜能力。
    NBD peptide
  • HY-175277
    PIM1-IN-8 Inhibitor
    PIM1-IN-8 是一种 PIM1/p65 通路抑制剂。PIM1-IN-8 抑制活化成纤维细胞中 α-SMA 和 I 型胶原的表达,并阻断 TGF-β 诱导的迁移。PIM1-IN-8 在 Bleomycin (BLM) (HY-17565A) 诱导的肺纤维化小鼠模型中缓解肺纤维化。PIM1-IN-8 可用于特发性肺纤维化 (IPF) 的研究。
    PIM1-IN-8
  • HY-B1328S1
    Pyridoxine-d3 Inhibitor
    Pyridoxine-d3 是氘代标记的Pyridoxine。Pyridoxine (Pyridoxol) 是一种吡啶衍生物。Pyridoxine 作用于阿尔茨海默病细胞模型,通过 Nrf-2/HO-1 途径发挥抗氧化作用。
    Pyridoxine-d<sub>3</sub>
  • HY-W995241
    BPD Inhibitor
    BPD 是一种 COX-2TAK1-NF-κB 抑制剂,对 COX-2IC50 为 18.5 μM。BPD 在转录水平上抑制 iNOS、TNF-α、IL-6 和 IL-1β 的表达。BPD 具有抗炎活性。BPD 可以抑制角叉菜胶引起的爪水肿和 LPS 引起的脓毒症死亡。
    BPD
  • HY-N3632
    Methoxycoronarin D Inhibitor
    Methoxycoronarin D 可以从 Hedychium coronarium J. Koenig 中分离得到,是一种 NF-κB 有效抑制剂,IC50 值为 7.3 μM。Methoxycoronarin D 还是一种 COX-1的选择性抑制剂,IC50 值为 0.9 μM。
    Methoxycoronarin D
  • HY-N0509R
    Astilbin (Standard)

    落新妇苷 (Standard)

    Inhibitor
    Astilbin (Standard) 是 Astilbin 的分析标准品。本产品用于研究及分析应用。Astilbin 是一种黄酮类化合物,可增强 NRF2 活化。Astilbin 还抑制 TNF-α 表达和 NF-κB 活化。
    Astilbin (Standard)
  • HY-137315S
    TML-6-d3
    TML-6-d3 是 TML-6 的氘代物。 TML-6 是一种口服有效的姜黄素衍生物,抑制 β-淀粉样前体蛋白和 β-淀粉样蛋白 () 的合成。TML-6 上调 Apo E,抑制 NF-κBmTOR,并增加抗氧化 Nrf2 基因的活性。TML-6 具有用于阿尔茨海默氏病 (AD) 研究的潜力。
    TML-6-d<sub>3</sub>
  • HY-131265
    Mesalamine impurity P

    美沙拉嗪EP杂质P

    Inhibitor
    Mesalamine impurity P 是 Mesalamine (HY-15027) 的杂质。5-Aminosalicylic acid (Mesalamine) 是一种特异性的 PPARγ 激动剂,还抑制 p21-激活激酶 1 (PAK1) 和 NF-κB。
    Mesalamine impurity P
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.